Listerine safety/efficacy for plaque, gingivitis claims recommended by FDA subcommittee.
This article was originally published in The Rose Sheet
Executive Summary
LISTERINE SAFETY AND EFFICACY FOR PLAQUE, GINGIVITIS CLAIMS RECOMMENDED by FDA's Dental Products Panel Plaque Subcommittee at its Oct. 29-30 meeting in Gaithersburg, Md. The subcommittee concluded that the active ingredient combination of essential oils in Warner-Lambert's Listerine mouthwash -- .064% thymol, .042% menthol, .092% eucalyptol and .06% menthol salicylate -- should be included in the oral health care products final monograph as a Category I (safe and effective) treatment for plaque and gingivitis.